60
In band
Moving averages
SMA 200$56.53+154.33%
Company profile
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$57.48B
P/E ratioNone
EPS$-8.41
Beta1.106
Dividend yield0.00%
52-week high$176.66
52-week low$22.28
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
VRTX
Vertex Pharmaceuticals Inc
RSI 46
CRSP
CRISPR Therapeutics AG
RSI 44
IOVA
Iovance Biotherapeutics Inc
RSI 69
VKTX
Viking Therapeutics Inc
RSI 40
SRPT
Sarepta Therapeutics Inc
RSI 55
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 57
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
RSI alerts for MRNA
Get an email the moment Moderna Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 5:34 AM EDT